Understanding Vape Counter-Marketing Study
Countering E-Cigarette Marketing in the Retail Environment Among Adolescents and Young Adults
The goal of this interventional study is to test whether short videos of electronic-cigarette (e-cigarette) counter-marketing lessons work to decrease people's intent to use and smoke e-cigarettes. Using short videos, the investigators hope to inform participants about the marketing strategies that e-cigarette companies use to try to get people to purchase and use e-cigarettes. The investigators hope to find that, after watching the short videos, people will be able to point out when e-cigarette companies are trying to sell their products, and hopefully they will have a lower interest in buying and using e-cigarettes. The investigators also hope participants will learn more about the addictiveness and harmfulness of using e-cigarettes by watching the short videos.
調査の概要
状態
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Shivani Gaiha, PhD
- 電話番号:617-355-3538
- メール:Shivani.Gaiha@childrens.harvard.edu
研究連絡先のバックアップ
- 名前:Madison O'Connell
- 電話番号:617-919-6964
- メール:madison.oconnell@childrens.harvard.edu
研究場所
-
-
Massachusetts
-
Boston、Massachusetts、アメリカ、02115
- Boston Children's Hospital
-
コンタクト:
- Shivani Gaiha, PhD
- 電話番号:617-355-3538
- メール:shivani.gaiha@childrens.harvard.edu
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- 13-21 years old
- Fluent in English
- Owns a smartphone or other device that can be used to complete study activities (e.g., watching videos, responding to electronic surveys)
- Meets sampling ratio to match the US Census for sex assigned at birth, race, and ethnicity
Exclusion Criteria:
- Fails survey validation checks (e.g., completing the survey too quickly, providing the same answer to every question)
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:防止
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:New Intervention Group
Participants in this arm will receive a novel intervention developed by the study team. |
Participants will view 4 short-form videos filmed by influencers. Influencers convey messaging designed to counter e-cigarette marketing in retail stores. |
|
アクティブコンパレータ:Pre-existing Intervention
Participants will receive a comparable, pre-existing intervention not developed by the study team. |
Participants will view 1 video in the public domain with messaging on e-cigarette marketing tactics. |
|
他の:Control Condition
Participants will receive a control condition that was not developed by the study team. |
Participants will view 4 short-form influencer-generated videos on topics that are unrelated to counter e-cigarette marketing in retail stores. |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Susceptibility to use e-cigarettes among those who never used
時間枠:From Day 1 (Baseline/Pre-intervention) to Day 31 (One-month follow-up after the treatment).
|
Susceptibility to use e-cigarettes among those who never used [Susceptibility scores are calculated based on the following 4 items:
O'Brien EK, Baig SA, Persoskie A. Developing and Validating Measures of Absolute and Relative E-Cigarette Product Risk Perceptions: Single Items Can Be Surprisingly Comprehensive. Nicotine Tob Res. 2022;24(3):316-323. doi:10.1093/ntr/n |
From Day 1 (Baseline/Pre-intervention) to Day 31 (One-month follow-up after the treatment).
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
E-cigarette Use
時間枠:From Day 1 (Baseline/Pre-intervention) to Day 31 (One-month follow-up after the treatment).
|
|
From Day 1 (Baseline/Pre-intervention) to Day 31 (One-month follow-up after the treatment).
|
|
Intent to use e-cigarettes and cigarettes
時間枠:From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)
|
Do participants plan to use e-cigarettes and cigarettes? |
From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)
|
|
Vaping attitudes and norms
時間枠:From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)
|
We will measure people's attitudes and acceptance towards vaping using: Vaping Attitudes Scale (5-point Likert-type; high score: positive attitude) and Mean Vaping Injunctive Norms Scale (3-item) |
From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)
|
|
Pro-vaping marketing exposure (focused on retail), including marketing receptivity
時間枠:From Day 1 (Baseline/Pre-intervention) Day 31 (One-month follow-up after the treatment)
|
Can people understand and recognize e-cigarette marketing? Does it have an effect on them? |
From Day 1 (Baseline/Pre-intervention) Day 31 (One-month follow-up after the treatment)
|
|
Marketing exposure on social media
時間枠:Day 1 (Baseline/Pre-intervention)
|
Questions to assess social media use, frequency, and platforms. |
Day 1 (Baseline/Pre-intervention)
|
|
Anti-vaping content exposure
時間枠:Day 1 (Baseline/Pre-intervention)
|
Prior exposure to having seen content that dissuades people from using vapes and locations where they saw it. |
Day 1 (Baseline/Pre-intervention)
|
|
Knowledge of e-cigarette retail marketing
時間枠:From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)
|
How much do people know about e-cigarette retail marketing (based on key messages and facts shown in video content)? |
From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)
|
|
Perceived message effectiveness
時間枠:Day 1 (Immediately post-intervention)
|
We will test the effectiveness of the videos using two scales, the Message Assessment Scale for Tobacco Prevention Campaigns, and the Perceived Message Effectiveness Scale (6-item). |
Day 1 (Immediately post-intervention)
|
|
Video acceptability
時間枠:Day 1 (Immediately post-treatment)
|
We will test how much people enjoyed and connected with the videos based on a quality rating scale and a question on alternative ways to receive content. |
Day 1 (Immediately post-treatment)
|
その他の成果指標
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Recruitment, enrollment, and attrition
時間枠:From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)
|
We want to measure recruitment and enrollment success, and how many people complete the study. |
From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)
|
|
Video feasibility
時間枠:Day 1 (Immediately post-intervention)
|
We want to test whether people were able to watch the videos, how many of them they watched and for how long, and what devices they used to watch them. |
Day 1 (Immediately post-intervention)
|
協力者と研究者
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
- 26-504
- R00CA267477 (米国 NIH グラント/契約)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。